WSA
TVTX icon

Wall Street Associates’s Travere Therapeutics TVTX Stock Holding History

Wall Street Associates’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.15M Sell
113,695
-85,000
-43% -$1.74M 1.42% 3
2016
Q3 		$4.45M Hold
198,695
– – 1.52% 6
2016
Q2 		$3.54M Hold
198,695
– – 1.42% 8
2016
Q1 		$2.71M Hold
198,695
– – 1.13% 16
2015
Q4 		$3.83M Sell
198,695
-115,000
-37% -$2.3M 1.08% 7
2015
Q3 		$6.36M Sell
313,695
-237,100
-43% -$7.02M 1.22% 11
2015
Q2 		$18.3M Sell
550,795
-9,900
-2% -$271K 1.72% 5
2015
Q1 		$13.4M Buy
560,695
+475,195
+556% +$7.25M 1.27% 9
2014
Q4 		$1.05M Buy
+85,500
New +$885K 0.1% 197

Other funds holding TVTX

SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $4.2B AUM 21.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return